ResearcherTokyo Medical UniversityNo recent work listed
Ryosuke Nakatsubo
Matched on ORCID iD 0000-0002-1120-4354; OpenAlex author ID A5077930483. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2021: 1 paper · 2022: none · 2023: 1 paper
Papers 2
- A fatal case of massive hemobilia caused by invasive pancreatic cancer with median arcuate ligament syndrome: A case report. Co-author DOI 10.1097/md.0000000000035701↗
- Novel Therapeutic Method for Unresectable Pancreatic Cancer-The Impact of the Long-Term Research in Therapeutic Effect of High-Intensity Focused Ultrasound (HI… Co-author DOI 10.3390/curroncol28060409↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shuntaro Mukai · 2 shared papers, 2021–2023 · strength 0.25
- Paper A fatal case of massive hemobilia caused by invasive pancreatic cancer with median arcuate ligament syndrome: A case re… DOI 10.1097/md.0000000000035701↗
- Paper Novel Therapeutic Method for Unresectable Pancreatic Cancer-The Impact of the Long-Term Research in Therapeutic Effect … DOI 10.3390/curroncol28060409↗
- Reina Tanaka · 2 shared papers, 2021–2023 · strength 0.25
- Paper A fatal case of massive hemobilia caused by invasive pancreatic cancer with median arcuate ligament syndrome: A case re… DOI 10.1097/md.0000000000035701↗
- Paper Novel Therapeutic Method for Unresectable Pancreatic Cancer-The Impact of the Long-Term Research in Therapeutic Effect … DOI 10.3390/curroncol28060409↗
- Atsushi Sofuni · 2 shared papers, 2021–2023 · strength 0.25
- Paper A fatal case of massive hemobilia caused by invasive pancreatic cancer with median arcuate ligament syndrome: A case re… DOI 10.1097/md.0000000000035701↗
- Paper Novel Therapeutic Method for Unresectable Pancreatic Cancer-The Impact of the Long-Term Research in Therapeutic Effect … DOI 10.3390/curroncol28060409↗
- Kenjiro Yamamoto · 2 shared papers, 2021–2023 · strength 0.25
- Paper A fatal case of massive hemobilia caused by invasive pancreatic cancer with median arcuate ligament syndrome: A case re… DOI 10.1097/md.0000000000035701↗
- Paper Novel Therapeutic Method for Unresectable Pancreatic Cancer-The Impact of the Long-Term Research in Therapeutic Effect … DOI 10.3390/curroncol28060409↗
- Yukitoshi Matsunami · 2 shared papers, 2021–2023 · strength 0.25
- Paper A fatal case of massive hemobilia caused by invasive pancreatic cancer with median arcuate ligament syndrome: A case re… DOI 10.1097/md.0000000000035701↗
- Paper Novel Therapeutic Method for Unresectable Pancreatic Cancer-The Impact of the Long-Term Research in Therapeutic Effect … DOI 10.3390/curroncol28060409↗
- Kazumasa Nagai · 2 shared papers, 2021–2023 · strength 0.25
- Paper A fatal case of massive hemobilia caused by invasive pancreatic cancer with median arcuate ligament syndrome: A case re… DOI 10.1097/md.0000000000035701↗
- Paper Novel Therapeutic Method for Unresectable Pancreatic Cancer-The Impact of the Long-Term Research in Therapeutic Effect … DOI 10.3390/curroncol28060409↗
- Ryosuke Tonozuka · 2 shared papers, 2021–2023 · strength 0.25
- Paper A fatal case of massive hemobilia caused by invasive pancreatic cancer with median arcuate ligament syndrome: A case re… DOI 10.1097/md.0000000000035701↗
- Paper Novel Therapeutic Method for Unresectable Pancreatic Cancer-The Impact of the Long-Term Research in Therapeutic Effect … DOI 10.3390/curroncol28060409↗
- Takao Itoi · 2 shared papers, 2021–2023 · strength 0.25
- Paper A fatal case of massive hemobilia caused by invasive pancreatic cancer with median arcuate ligament syndrome: A case re… DOI 10.1097/md.0000000000035701↗
- Paper Novel Therapeutic Method for Unresectable Pancreatic Cancer-The Impact of the Long-Term Research in Therapeutic Effect … DOI 10.3390/curroncol28060409↗
- Yasutsugu Asai · 1 shared paper, 2021 · strength 0.10
- Yuichi Nagakawa · 1 shared paper, 2021 · strength 0.10
- Akihiko Tsuchida · 1 shared paper, 2021 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.